Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease - Wikidata - awgldk - TriplyDB

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q35268320

about

Aclidinium bromide for stable chronic obstructive pulmonary disease Aclidinium bromide for stable chronic obstructive pulmonary disease Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Safety and tolerability of inhalational anticholinergics in COPD Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD.The role of aclidinium bromide in the treatment of chronic obstructive pulmonary disease.Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.Emerging Therapeutic Options for the Management of COPD.

P2860

Q24193506-4E42100B-3D0A-4ADE-86E6-E2F20442526A Q24197522-21CD2E9C-C3E8-413C-88EF-D9B4B483E92F Q35538249-FAB19DF0-DA9F-4535-84CA-935BC9BC9816 Q36680246-CAE848A4-7D75-41C7-B8A9-E94F907C3316 Q38057220-09A20FD6-8F76-4167-8D80-9E8DE81F3D90 Q38287153-58B373D5-218F-4C80-94B1-FCA3C5DD3E5F Q38371305-E282F717-54E2-46EF-A9C1-9E9B8AE81B4A Q39936577-72890F2B-2C3C-4CFF-A370-E40E35E5892F

P2860

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q35268320

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

@ast

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

@en

type

label

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

@ast

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

@en

prefLabel

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

@ast

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

@en

P1433

Q35268320-D6EDD008-AF6F-486B-9807-2FB52FE40FB8

P1476

Q35268320-9B40514B-92DB-4F77-858A-8360F9A70740

P2093

Q35268320-97016FB9-F17C-4C70-B455-5609380B44A4

Q35268320-C4C41F5C-4BB5-4334-BA04-562030E1A991

P2860

Q35268320-02476437-9D3E-4C4C-80BE-853AB5CD661C

Q35268320-03FE3E2B-E195-4A72-B623-0980EBB75256

Q35268320-05C14AD9-A2FB-4B7C-88D3-1B272C65A486

Q35268320-09421BD0-2796-409C-BC81-E259A02CA1D9

Q35268320-09A88691-E2CB-47ED-8268-A43E7C144DF8

Q35268320-0DFCFEB4-4AD7-41BB-8E94-F4738160A8C0

Q35268320-0E0D5264-8167-43D7-B95B-471DBCDEC706

Q35268320-0FB78E1A-E69F-4991-A070-34F4157A0389

Q35268320-131B8989-80B2-4F5F-9CA3-64429C14902A

Q35268320-16919168-04F0-4986-B8DF-AB70AC335E80

P304

Q35268320-C2CD90CF-7510-463E-9C08-4B9FAED5890B

P31

Q35268320-B75E7536-7F1E-42B4-B380-45E212A840BB

Q35268320-F54DB618-F905-43FB-8EDB-E4F90A8F78E3

P356

Q35268320-772A35CE-E687-4C3B-89C7-AF449CCFF600

P407

Q35268320-CD5CDBE1-20EB-41A1-8704-32C2317D2652

P478

Q35268320-95124875-5124-43D1-9BC1-15E7CAACFF14

P577

Q35268320-0FAD1F44-CDF6-4FF7-8F7D-AD6594364B62

P698

Q35268320-FEE6E67E-6277-4A28-B92B-1043373E6CCD

P921

Q35268320-1B75749D-24B3-4A4D-B5E8-F0EC57CC9C7A

Q35268320-2C587262-468D-4544-AA2A-B7A3E69BD9B2

Q35268320-3ACD204A-C03A-4A43-8545-0143F8C95713

Q35268320-681FFACD-1753-47BA-BC70-FBFE27332502

Q35268320-82D72A80-13B4-4007-8DFA-9E1048461E8B

Q35268320-D0BFBDCD-2156-4FA5-907E-F5A3B793826B

P932

Q35268320-1F16BAE9-D654-47D0-AD6A-2F16559F1D29

P356

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

@en

P2093

Michael W Sims

http://www.w3.org/2001/XMLSchema#string

Reynold A Panettieri

http://www.w3.org/2001/XMLSchema#string

P2860

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

The nature of small-airway obstruction in chronic obstructive pulmonary disease

The pharmacological properties of tiotropium.

Why particle size should affect clinical response to inhaled therapy.

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.

The role of anticholinergics in chronic obstructive pulmonary disease.

P304

457-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S15524

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22003291

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

chronic obstructive pulmonary disease

aclidinium bromide

mechanism of action

Anagraw amesgunef

P932

3186744

http://www.w3.org/2001/XMLSchema#string